Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

ENDOLUNG Trial. A Phase 1/2 Study of the Akt/mTOR Inhibitor and Autophagy Inducer Ibrilatazar (ABTL0812) in Combination with Paclitaxel/carboplatin in Patients with Advanced/recurrent Endometrial Cancer

Alexandra Leary,Purificación Estévez-García,Renaud Sabatier,Isabelle Ray-Coquard,Margarita Romeo,Pilar Barretina-Ginesta,Marta Gil-Martin,Elena Garralda,Joaquim Bosch-Barrera,Teresa Morán,Paloma Martin-Martorell,Ernest Nadal,Pere Gascón,Jordi Rodon,Jose M Lizcano,Pau Muñoz-Guardiola, Gemma Fierro-Durán, Oriol Pedrós-Gámez,Héctor Pérez-Montoyo,Marc Yeste-Velasco,Marc Cortal, Antonio Pérez-Campos,Jose Alfon,Carles Domenech,Alejandro Pérez-Fidalgo,Ana Oaknin

BMC Cancer（2024）

Cited 0|Views8
Key words
Endometrial cancer,Autophagy,Chemotherapy,Phase 1/2,Safety profile
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined